Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

These methods help understand cell structures and reactions.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

The new compound may be a safer alternative to finasteride for prostate protection.

The occipital scalp is affected in advanced hair loss, so it shouldn't be used as a control.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

COVID-19-positive patients with prosthetic speech implants face increased risks and need special care.

Laryngectomy patients need special protection and care during COVID-19 to prevent infection.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Ocrelizumab may cause total body hair loss in some patients.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Plant-based ingredients are effective and safe for modern skincare products.

Sheep wool follicles absorb different amino acids at various rates and locations, which could affect wool growth based on diet and genetics.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Co-trimoxazole may help treat autoimmune diseases.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

The rash resolved after stopping ponatinib.

Ritlecitinib works well and is safe for treating alopecia areata.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.